Home › Bladder Cancer › Oregon › Eugene
Bladder Cancer clinical trials in Eugene, OR
3 studies for Bladder Cancer are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Williamette Valley Cancer Institute and Research Center, Eugene
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- Oncology Associates of Oregon, P.C., Eugene
- Oncology Associates of Oregon, P.C., Springfield · 3 mi away
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RecruitingPhase 2
- Oregon Urology Institute, Springfield · 3 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- Edison, NJ22 studies
- St. Louis, MO22 studies
- Chicago, IL21 studies
- Seattle, WA21 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Endometrial Cancer8 studies
- Breast Cancer7 studies
- Cancer (all types)6 studies
- Chronic Lymphocytic Leukemia6 studies
- Multiple Myeloma6 studies
- Metastatic Cancer6 studies
- Macular Degeneration5 studies
- Lung Cancer5 studies
- Drug Use and Addiction5 studies
- Obesity4 studies
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.